J Nat Cancer I:冷冻疗法或为癌症治疗带来意想不到的好结果!

2017-10-13 枫丹白露 来宝网

“国家癌症研究所”杂志发表的一项新研究发现,特别是化疗患者在90分钟内穿着冷冻手套和袜子,可用于预防神经病变的症状。

研究发现冷冻疗法可能有效控制癌症治疗副作用】“国家癌症研究所”杂志发表的一项新研究发现,特别是化疗患者在90分钟内穿着冷冻手套和袜子,可用于预防神经病变的症状。

化疗诱发的周围神经病变是癌症治疗的常见且治疗无效的副作用。患者经历的疼痛,麻木和麻痹会降低其生活质量,并常常导致他们延迟治疗,减少剂量或完全停止治疗。推荐使用度洛西汀治疗神经病变;然而,其对于改善化疗引起的疼痛的效力有限。此外,没有针对化疗患者预防神经病的既定策略。

研究人员前瞻性地评估了冷冻治疗神经病预防的疗效。每周用紫杉醇(80mg / m2一小时)治疗的乳腺癌患者在其身体一侧戴上冷冻手套和袜子90分钟,包括药物输注的整个持续时间。研究人员将治疗方面的症状与未治疗侧的症状进行比较。主要目的是通过预处理基线的触觉敏感性变化评估的神经病变发生率。研究人员还评估了主观症状(如患者问卷中报告的)和患者的手动灵巧度。

在40例患者中,4例未达到累积剂量(由于发生肺炎,严重疲劳,肝功能异常和黄斑水肿),36名患者进行分析。客观和主观神经病征的发生率在干预方面在临床和统计学上显着低于所有测量的对照组。

研究人员报告说,他们的研究支持冷冻治疗对化学疗法诱导的周围神经病变预防的疗效,临床和统计学上显着降低患者报告的主观症状,客观体征(触觉和热敏感)减少,以及预防手动灵敏度降低等都证实了这一点。在紫杉醇治疗过程中,主观神经病症状的发展有临床和统计学显着延迟,累积剂量为960 mg / m2的主观神经病变几乎完全可以预防,干预后神经病变发生率较低。

研究结果表明,该疗法可能是预防接受紫杉醇治疗的癌症患者神经病变的有效策略。治疗可以通过预防剂量延迟或减少,以及抑制癌症患者在治疗期间和治疗后的生活质量的恶化来支持最佳化疗的递送。

乳腺癌的领导者黎明·赫什曼(Dawn Hershman)写道:“如果结果得到确认,冷冻治疗的副作用特征有限,成本低廉,除了神经性疼痛之外,似乎可以预防神经病变的成分。哥伦比亚大学赫伯特·欧文综合癌症中心的癌症计划,在一篇社论的存在下进行了研究。 “最终更好地了解引起化学疗法诱导的周围神经病变的生物学机制将提高我们有效预防和治疗所有这些毒性成分的能力。”

原始出处:

Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, et al. Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: 5 Prospective Self-Controlled Trial. Journal Of The National Cancer Institute (2017). DOI: 10.1093/jnci/djx178.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1650151, encodeId=2f011650151f0, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Dec 02 07:25:00 CST 2017, time=2017-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882521, encodeId=4c941882521a4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 01 19:25:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844241, encodeId=cffe1844241f4, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Aug 01 15:25:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255146, encodeId=0e9025514615, content=不错的.学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Oct 22 19:13:15 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254288, encodeId=ee8125428825, content=非常好.学习了.很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Oct 19 11:37:41 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253297, encodeId=1e8025329e18, content=有前景的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/mzZkwf53jx0oribz8WkmVTPTSib4iaRMXz6nkEOaqWPjgyYWQoLa8J2WCicWvb8SrhhZz5sgUcwmQnMQ1lJcA7Fhxg/0, createdBy=9b182084756, createdName=yunger, createdTime=Mon Oct 16 06:55:39 CST 2017, time=2017-10-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1650151, encodeId=2f011650151f0, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Dec 02 07:25:00 CST 2017, time=2017-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882521, encodeId=4c941882521a4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 01 19:25:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844241, encodeId=cffe1844241f4, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Aug 01 15:25:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255146, encodeId=0e9025514615, content=不错的.学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Oct 22 19:13:15 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254288, encodeId=ee8125428825, content=非常好.学习了.很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Oct 19 11:37:41 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253297, encodeId=1e8025329e18, content=有前景的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/mzZkwf53jx0oribz8WkmVTPTSib4iaRMXz6nkEOaqWPjgyYWQoLa8J2WCicWvb8SrhhZz5sgUcwmQnMQ1lJcA7Fhxg/0, createdBy=9b182084756, createdName=yunger, createdTime=Mon Oct 16 06:55:39 CST 2017, time=2017-10-16, status=1, ipAttribution=)]
    2018-05-01 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=1650151, encodeId=2f011650151f0, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Dec 02 07:25:00 CST 2017, time=2017-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882521, encodeId=4c941882521a4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 01 19:25:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844241, encodeId=cffe1844241f4, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Aug 01 15:25:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255146, encodeId=0e9025514615, content=不错的.学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Oct 22 19:13:15 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254288, encodeId=ee8125428825, content=非常好.学习了.很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Oct 19 11:37:41 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253297, encodeId=1e8025329e18, content=有前景的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/mzZkwf53jx0oribz8WkmVTPTSib4iaRMXz6nkEOaqWPjgyYWQoLa8J2WCicWvb8SrhhZz5sgUcwmQnMQ1lJcA7Fhxg/0, createdBy=9b182084756, createdName=yunger, createdTime=Mon Oct 16 06:55:39 CST 2017, time=2017-10-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1650151, encodeId=2f011650151f0, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Dec 02 07:25:00 CST 2017, time=2017-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882521, encodeId=4c941882521a4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 01 19:25:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844241, encodeId=cffe1844241f4, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Aug 01 15:25:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255146, encodeId=0e9025514615, content=不错的.学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Oct 22 19:13:15 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254288, encodeId=ee8125428825, content=非常好.学习了.很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Oct 19 11:37:41 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253297, encodeId=1e8025329e18, content=有前景的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/mzZkwf53jx0oribz8WkmVTPTSib4iaRMXz6nkEOaqWPjgyYWQoLa8J2WCicWvb8SrhhZz5sgUcwmQnMQ1lJcA7Fhxg/0, createdBy=9b182084756, createdName=yunger, createdTime=Mon Oct 16 06:55:39 CST 2017, time=2017-10-16, status=1, ipAttribution=)]
    2017-10-22 虈亣靌

    不错的.学习了!谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1650151, encodeId=2f011650151f0, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Dec 02 07:25:00 CST 2017, time=2017-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882521, encodeId=4c941882521a4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 01 19:25:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844241, encodeId=cffe1844241f4, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Aug 01 15:25:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255146, encodeId=0e9025514615, content=不错的.学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Oct 22 19:13:15 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254288, encodeId=ee8125428825, content=非常好.学习了.很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Oct 19 11:37:41 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253297, encodeId=1e8025329e18, content=有前景的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/mzZkwf53jx0oribz8WkmVTPTSib4iaRMXz6nkEOaqWPjgyYWQoLa8J2WCicWvb8SrhhZz5sgUcwmQnMQ1lJcA7Fhxg/0, createdBy=9b182084756, createdName=yunger, createdTime=Mon Oct 16 06:55:39 CST 2017, time=2017-10-16, status=1, ipAttribution=)]
    2017-10-19 虈亣靌

    非常好.学习了.很受益

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1650151, encodeId=2f011650151f0, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Dec 02 07:25:00 CST 2017, time=2017-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882521, encodeId=4c941882521a4, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 01 19:25:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844241, encodeId=cffe1844241f4, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Aug 01 15:25:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255146, encodeId=0e9025514615, content=不错的.学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Oct 22 19:13:15 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254288, encodeId=ee8125428825, content=非常好.学习了.很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Oct 19 11:37:41 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253297, encodeId=1e8025329e18, content=有前景的技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/mzZkwf53jx0oribz8WkmVTPTSib4iaRMXz6nkEOaqWPjgyYWQoLa8J2WCicWvb8SrhhZz5sgUcwmQnMQ1lJcA7Fhxg/0, createdBy=9b182084756, createdName=yunger, createdTime=Mon Oct 16 06:55:39 CST 2017, time=2017-10-16, status=1, ipAttribution=)]
    2017-10-16 yunger

    有前景的技术

    0

相关资讯

C&EN:癌症新药PARP抑制剂获批,完美利用癌细胞弱点,粉碎它们的基因!

癌症这一令人闻风丧胆的疾病,影响着越来越多的人们,除了传统的手术及放化疗之外,新方法不断涌出,其中最为突出的就是免疫疗法,大幅的提高了癌症患者的寿命。然而,新的癌症治疗方法虽然给癌症患者带来了一线希望,但是选择却很有局限性,对另一些人来说,新药物和新方法并不适用,因此,他们仍处于无尽的等待中。近期,一种基于“合成杀伤力”的新药概念进入了人们的视野,为广大癌症患者带来了一丝曙光。研究结果以封面故事的

Oncotarget:新型抗癌药获批,成功击败引发癌症的重要基因!

阻止Ras癌基因的功能被许多科学家认为是癌症治疗学的“圣杯”,因为这些基因的突变驱动了许多不同类型的癌症的生长。在人类中发现的三种Ras基因--H-Ras,K-Ras和N-Ras - 是第一个与癌症发展相关的新基因,以及由VCU Massey癌症中心研究员Paul Dent博士领导的新研究,已经显示最近批准的乳腺癌药物neratinib可以通过意想不到的过程阻断Ras以及其他几种癌基因的功能。

27种病毒可在精液中藏身:包括腮腺炎病毒,或可引发癌症

埃博拉病毒的庇护所一组来自英国的研究人员发现,一些曾感染寨卡病毒的男性感染症状消失数月后,在他们的精液中仍有少量寨卡病毒RNA残留。此外,在2015年3月,利比里亚蒙罗维亚的一名妇女因感染埃博拉病毒而死亡,当时利比里亚已经宣布消除埃博拉病毒,而这名女子唯一已知的病毒暴露是与一名埃博拉幸存者进行无保护措施的性交。在这名男子首次发病后的199天,他的精液检测仍为阳性。同时,基因分析显示两者的感染密

Nature Genetics:小鼠癌症模型—它们真的有效吗?

“这一假设的前提在于PDX能反映患者体内大部分肿瘤的情况。但是,肿瘤基因组发生了极大的变化,”

Nature Materials:癌症液体活检获重大突破

来自中山大学肿瘤防治中心,加州大学圣地亚哥分校等处的研究人员证实可以通过检测少量血液中循环肿瘤DNA(ctDNA)特定位点甲基化水平,早期诊断和预后预测肝细胞癌(HCC)。

Science:基因编辑疗法在中国已占先机,在癌症、遗传病治疗等领域 9 项试验值得关注

基因编辑被誉为 21 世纪最伟大的生物医学突破技术之一,人们对该技术未来在癌症、遗传病领域的突破性成果给予了厚望。上周,《科学》杂志刊文评述了中国在基因编辑疗法中的最新进展,下面让我们一同来了解国际同行如何看待中国科学家在基因编辑临床应用领域取得的前沿成果。